HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?

Author(s):: Karalis, I.; Jukema, J.W. (0000-0002-3246-8359)

Published: 2018
Publication type: Article / Letter to editor

HDL mimeticsReverse cholesterol transportCoronary artery diseaseAtherosclerosisCETP inhibitors

Date issued: 2018-08-31
Language: English
Is part of: Current Cardiology Reports (2018), No. 8
hdl: 1887/86904
doi: 10.1007/s11886-018-1004-9
URL: https://link.springer.com/article/10.1007/s11886-018-1004-9